serology
Last reviewed 01/2018
There is a rise in serum transaminases 22-40 days after exposure.
Serum antibody to HAV appears as the stool becomes negative for virus:
- serum IgM anti-HAV
- implies recent infection
- detectable about 3 weeks after exposure and increases in titre over 4–6 weeks, it persists for 2-6 months (rarely for up to one year) in low titre then declines to non-detectable levels (2)
- negative tests should be repeated if taken <5 days after the onset of symptoms to exclude a false-negative result (3)
- when the test result is reactive but probable non-specific IgM reactivity, repeat the test (3)
- false positive IgM are more common in the elderly and should be interpreted with caution (since they are likely to have had hepatitis A in childhood) (4)
- serum IgG anti-HAV
- persists for many years (usually lifelong)
- probably conveys immunity to further infection with HAV (1)
Other investigations include:
- serum/plasma alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels – 500-10,000 i.u./l
- billirubin – upto 500 micromoles/litre
- alkaline phosphatase levels
- prothrombin time – if prolonged for more than 5 seconds suggests developing hepatic decompensation (5)
Reference:
- (1) World Health Organization (WHO) 2009. The global prevalence of hepatitis A virus infection and susceptibility: a systematic review
- (2) World Health Organization (WHO) 2003. Department of Communicable Disease Surveillance and Response. Hepatitis A vaccine
- (3) Health Protection Agency (HPA) 2007. Hepatitis A virus acute serology - minimum testing algorithm. National Standard Method VSOP 27
- (4) Health Protection Agency (HPA) 2009. Guidance for the prevention and control of hepatitis A infection
- (5) British Association for Sexual Health and HIV (BASHH) 2008. United Kingdom national guideline on the management of the viral hepatitides A, B & C 2008